Macleods Pharma USA, Inc. has recalled approximately 31,968 bottles of Pioglitazone Hydrochloride (Actos) 15 mg tablets, a prescription medication used to manage blood sugar in adults with type 2 diabetes. The recall was issued because the tablets were found to be superpotent, meaning they contain more of the active ingredient than specified. Consumers should contact their healthcare provider or pharmacist immediately to discuss their treatment and how to return the affected medication.
Because these tablets are superpotent, they contain an excessively high dose of the medication which can cause blood sugar levels to drop dangerously low (hypoglycemia). This condition can lead to symptoms like dizziness, confusion, or loss of consciousness if not addressed.
Healthcare consultation and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.